These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 7775617)
1. Clinical review 70: Approaches to the prevention of breast cancer. Love RR J Clin Endocrinol Metab; 1995 Jun; 80(6):1757-60. PubMed ID: 7775617 [TBL] [Abstract][Full Text] [Related]
2. Prevention of breast cancer in premenopausal women. Love RR J Natl Cancer Inst Monogr; 1994; (16):61-5. PubMed ID: 7999471 [TBL] [Abstract][Full Text] [Related]
3. An appraisal of strategies to reduce the incidence of breast cancer. Jordan VG; Morrow M Stem Cells; 1993 Jul; 11(4):252-62. PubMed ID: 8401248 [TBL] [Abstract][Full Text] [Related]
4. Sex steroids and breast cancer prevention. Spicer DV; Pike MC J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of breast cancer. Castrellon AB; Glück S Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291 [TBL] [Abstract][Full Text] [Related]
6. Vascular effects of aromatase inhibitors: data from clinical trials. Howell A; Cuzick J J Steroid Biochem Mol Biol; 2005 May; 95(1-5):143-9. PubMed ID: 15936188 [TBL] [Abstract][Full Text] [Related]
7. New approaches to the endocrine prevention and treatment of breast cancer. Howell A; Howell SJ; Evans DG Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S39-44. PubMed ID: 12819938 [TBL] [Abstract][Full Text] [Related]
8. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Lee WL; Chao HT; Cheng MH; Wang PH Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794 [TBL] [Abstract][Full Text] [Related]
9. Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives. Del Mastro L; Levaggi A; Giraudi S; Pronzato P Cancer Treat Rev; 2011 May; 37(3):208-11. PubMed ID: 20724078 [TBL] [Abstract][Full Text] [Related]
10. The prevention of breast cancer through reduced ovarian steroid exposure. Spicer DV; Pike MC Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631 [TBL] [Abstract][Full Text] [Related]
11. The endocrine prevention of breast cancer. Howell A Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):615-23. PubMed ID: 18971122 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen and breast cancer--from palliation to prevention. Rich SE Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194 [TBL] [Abstract][Full Text] [Related]
13. Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings. Ingle JN Clin Cancer Res; 2005 Jan; 11(2 Pt 2):900s-5s. PubMed ID: 15701884 [TBL] [Abstract][Full Text] [Related]
14. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts. Vogel VG Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233 [TBL] [Abstract][Full Text] [Related]
15. [Breakthrough in breast cancer chemoprevention]. Kahán Z; Thurzó L Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784 [TBL] [Abstract][Full Text] [Related]
16. Translational approaches for the prevention of estrogen receptor-negative breast cancer. Li Y; Brown PH Eur J Cancer Prev; 2007 Jun; 16(3):203-15. PubMed ID: 17415091 [TBL] [Abstract][Full Text] [Related]
18. Hormonal approaches to breast cancer treatment and prevention: an overview. Vogel CL Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459 [TBL] [Abstract][Full Text] [Related]
19. Ovarian ablation as treatment for young women with breast cancer. Davidson NE J Natl Cancer Inst Monogr; 1994; (16):95-9. PubMed ID: 7528032 [TBL] [Abstract][Full Text] [Related]
20. The prevention of breast cancer. Prichard RS; Hill AD; Dijkstra B; McDermott EW; O'Higgins NJ Br J Surg; 2003 Jul; 90(7):772-83. PubMed ID: 12854100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]